{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T05:52:14Z","timestamp":1792043534738,"version":"4.4.0"},"reference-count":250,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"DOI":"10.1038\/s41568-026-00979-z","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:12:28Z","timestamp":1790093548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Replication stress in cancer: origins, consequences and therapeutic opportunities"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1493-2189","authenticated-orcid":false,"given":"Junjie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena, S. & Zou, L. Hallmarks of DNA replication stress. Mol. Cell 82, 2298\u20132314 https:\/\/doi.org\/10.1016\/j.molcel.2022.05.004 (2022).","journal-title":"Mol. Cell"},{"key":"979_CR2","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1126\/science.272.5264.1030","volume":"272","author":"AM Deshpande","year":"1996","unstructured":"Deshpande, A. M. & Newlon, C. S. DNA replication fork pause sites dependent on transcription. Science 272, 1030\u20131033 https:\/\/doi.org\/10.1126\/science.272.5264.1030 (1996).","journal-title":"Science"},{"key":"979_CR3","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1126\/science.288.5471.1643","volume":"288","author":"K Labib","year":"2000","unstructured":"Labib, K., Tercero, J. A. & Diffley, J. F. Uninterrupted MCM2\u20137 function required for DNA replication fork progression. Science 288, 1643\u20131647 https:\/\/doi.org\/10.1126\/science.288.5471.1643 (2000).","journal-title":"Science"},{"key":"979_CR4","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s0092-8674(03)00569-5","volume":"114","author":"M Anglana","year":"2003","unstructured":"Anglana, M., Apiou, F., Bensimon, A. & Debatisse, M. Dynamics of DNA replication in mammalian somatic cells: nucleotide pool modulates origin choice and interorigin spacing. Cell 114, 385\u2013394 https:\/\/doi.org\/10.1016\/s0092-8674(03)00569-5 (2003).","journal-title":"Cell"},{"key":"979_CR5","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1126\/science.1083430","volume":"300","author":"L Zou","year":"2003","unstructured":"Zou, L. & Elledge, S. J. Sensing DNA damage through ATRIP recognition of RPA\u2013ssDNA complexes. Science 300, 1542\u20131548 https:\/\/doi.org\/10.1126\/science.1083430 (2003). This study demonstrates that RPA-coated ssDNA is a structure induced by replication stress that activates the ATR checkpoint pathway.","journal-title":"Science"},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nature03445","volume":"434","author":"H Farmer","year":"2005","unstructured":"Farmer, H. et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434, 917\u2013921 https:\/\/doi.org\/10.1038\/nature03445 (2005).","journal-title":"Nature"},{"key":"979_CR7","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/nature03443","volume":"434","author":"HE Bryant","year":"2005","unstructured":"Bryant, H. E. et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434, 913\u2013917 https:\/\/doi.org\/10.1038\/nature03443 (2005). Together with Farmer et al. (2005), this study shows the use of PARP inhibitor to induce synthetic lethality and selectively kill BRCA-deficient cancer cells.","journal-title":"Nature"},{"key":"979_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2897","volume":"16","author":"MK Zeman","year":"2014","unstructured":"Zeman, M. K. & Cimprich, K. A. Causes and consequences of replication stress. Nat. Cell Biol. 16, 2\u20139 https:\/\/doi.org\/10.1038\/ncb2897 (2014).","journal-title":"Nat. Cell Biol."},{"key":"979_CR9","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/nature03482","volume":"434","author":"J Bartkova","year":"2005","unstructured":"Bartkova, J. et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434, 864\u2013870 https:\/\/doi.org\/10.1038\/nature03482 (2005).","journal-title":"Nature"},{"key":"979_CR10","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nature03485","volume":"434","author":"VG Gorgoulis","year":"2005","unstructured":"Gorgoulis, V. G. et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature 434, 907\u2013913 https:\/\/doi.org\/10.1038\/nature03485 (2005). Together with Bartkova et al. (2005), this study shows that the DNA damage checkpoint is a barrier to the increase of genomic instability in cancer cells.","journal-title":"Nature"},{"key":"979_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-012414-040424","volume":"10","author":"M Macheret","year":"2015","unstructured":"Macheret, M. & Halazonetis, T. D. DNA replication stress as a hallmark of cancer. Annu. Rev. Pathol. 10, 425\u2013448 https:\/\/doi.org\/10.1146\/annurev-pathol-012414-040424 (2015).","journal-title":"Annu. Rev. Pathol."},{"key":"979_CR12","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.molcel.2011.10.013","volume":"44","author":"A Helmrich","year":"2011","unstructured":"Helmrich, A., Ballarino, M. & Tora, L. Collisions between replication and transcription complexes cause common fragile site instability at the longest human genes. Mol. Cell 44, 966\u2013977 https:\/\/doi.org\/10.1016\/j.molcel.2011.10.013 (2011).","journal-title":"Mol. Cell"},{"key":"979_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.cell.2011.03.044","volume":"145","author":"AC Bester","year":"2011","unstructured":"Bester, A. C. et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145, 435\u2013446 https:\/\/doi.org\/10.1016\/j.cell.2011.03.044 (2011).","journal-title":"Cell"},{"key":"979_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.molcel.2019.04.027","volume":"74","author":"D Cortez","year":"2019","unstructured":"Cortez, D. Replication-coupled DNA repair. Mol. Cell 74, 866\u2013876 https:\/\/doi.org\/10.1016\/j.molcel.2019.04.027 (2019).","journal-title":"Mol. Cell"},{"key":"979_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/nature11935","volume":"494","author":"RA Burrell","year":"2013","unstructured":"Burrell, R. A. et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 494, 492\u2013496 https:\/\/doi.org\/10.1038\/nature11935 (2013).","journal-title":"Nature"},{"key":"979_CR16","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41568-022-00518-6","volume":"23","author":"E Cybulla","year":"2023","unstructured":"Cybulla, E. & Vindigni, A. Leveraging the replication stress response to optimize cancer therapy. Nat. Rev. Cancer 23, 6\u201324 https:\/\/doi.org\/10.1038\/s41568-022-00518-6 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"979_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature05268","volume":"444","author":"J Bartkova","year":"2006","unstructured":"Bartkova, J. et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444, 633\u2013637 https:\/\/doi.org\/10.1038\/nature05268 (2006).","journal-title":"Nature"},{"key":"979_CR18","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.molcel.2015.12.004","volume":"61","author":"J Zimmer","year":"2016","unstructured":"Zimmer, J. et al. Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds. Mol. Cell 61, 449\u2013460 https:\/\/doi.org\/10.1016\/j.molcel.2015.12.004 (2016).","journal-title":"Mol. Cell"},{"key":"979_CR19","doi-asserted-by":"publisher","first-page":"7049","DOI":"10.1093\/nar\/gkr420","volume":"39","author":"I Elvers","year":"2011","unstructured":"Elvers, I., Johansson, F., Groth, P., Erixon, K. & Helleday, T. UV stalled replication forks restart by re-priming in human fibroblasts. Nucleic Acids Res. 39, 7049\u20137057 https:\/\/doi.org\/10.1093\/nar\/gkr420 (2011).","journal-title":"Nucleic Acids Res."},{"key":"979_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1006007","volume":"12","author":"T Wilhelm","year":"2016","unstructured":"Wilhelm, T. et al. Slow replication fork velocity of homologous recombination-defective cells results from endogenous oxidative stress. PLoS Genet. 12, e1006007 https:\/\/doi.org\/10.1371\/journal.pgen.1006007 (2016).","journal-title":"PLoS Genet."},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/nature11368","volume":"489","author":"JI Garaycoechea","year":"2012","unstructured":"Garaycoechea, J. I. et al. Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature 489, 571\u2013575 https:\/\/doi.org\/10.1038\/nature11368 (2012). This study demonstrates that endogenous aldehydes inflict severe DNA damage on haematopoietic stem cells, requiring a dual protection system of aldehyde clearance and Fanconi anaemia DNA repair to prevent stem cell attrition and bone marrow failure.","journal-title":"Nature"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1146\/annurev-biochem-080320-112510","volume":"90","author":"DR Semlow","year":"2021","unstructured":"Semlow, D. R. & Walter, J. C. Mechanisms of vertebrate DNA interstrand cross-link repair. Annu. Rev. Biochem. 90, 107\u2013135 https:\/\/doi.org\/10.1146\/annurev-biochem-080320-112510 (2021).","journal-title":"Annu. Rev. Biochem."},{"key":"979_CR23","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1158\/0008-5472.CAN-16-3389","volume":"77","author":"R Buisson","year":"2017","unstructured":"Buisson, R., Lawrence, M. S., Benes, C. H. & Zou, L. APOBEC3A and APOBEC3B activities render cancer cells susceptible to ATR inhibition. Cancer Res. 77, 4567\u20134578 https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3389 (2017).","journal-title":"Cancer Res."},{"key":"979_CR24","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1158\/0008-5472.CAN-16-3394","volume":"77","author":"AM Green","year":"2017","unstructured":"Green, A. M. et al. Cytosine deaminase APOBEC3A sensitizes leukemia cells to inhibition of the DNA replication checkpoint. Cancer Res. 77, 4579\u20134588 https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-3394 (2017).","journal-title":"Cancer Res."},{"key":"979_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.molcel.2023.11.014","volume":"84","author":"L Milano","year":"2024","unstructured":"Milano, L., Gautam, A. & Caldecott, K. W. DNA damage and transcription stress. Mol. Cell 84, 70\u201379 https:\/\/doi.org\/10.1016\/j.molcel.2023.11.014 (2024).","journal-title":"Mol. Cell"},{"key":"979_CR26","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cell.2017.07.043","volume":"170","author":"S Hamperl","year":"2017","unstructured":"Hamperl, S., Bocek, M. J., Saldivar, J. C., Swigut, T. & Cimprich, K. A. Transcription\u2013replication conflict orientation modulates R-loop levels and activates distinct DNA damage responses. Cell 170, 774\u2013786.e19 https:\/\/doi.org\/10.1016\/j.cell.2017.07.043 (2017).","journal-title":"Cell"},{"key":"979_CR27","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.1016\/j.molcel.2022.04.014","volume":"82","author":"JR Brickner","year":"2022","unstructured":"Brickner, J. R., Garzon, J. L. & Cimprich, K. A. Walking a tightrope: the complex balancing act of R-loops in genome stability. Mol. Cell 82, 2267\u20132297 https:\/\/doi.org\/10.1016\/j.molcel.2022.04.014 (2022).","journal-title":"Mol. Cell"},{"key":"979_CR28","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41580-022-00474-x","volume":"23","author":"E Petermann","year":"2022","unstructured":"Petermann, E., Lan, L. & Zou, L. Sources, resolution and physiological relevance of R-loops and RNA\u2013DNA hybrids. Nat. Rev. Mol. Cell Biol. 23, 521\u2013540 https:\/\/doi.org\/10.1038\/s41580-022-00474-x (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"979_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13087","volume":"7","author":"P Kotsantis","year":"2016","unstructured":"Kotsantis, P. et al. Increased global transcription activity as a mechanism of replication stress in cancer. Nat. Commun. 7, 13087 https:\/\/doi.org\/10.1038\/ncomms13087 (2016).","journal-title":"Nat. Commun."},{"key":"979_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.12.019","author":"L Uhl","year":"2026","unstructured":"Uhl, L. et al. MYC binding to nascent RNA suppresses innate immune signaling by R-loop-derived RNA-DNA hybrids. Cell https:\/\/doi.org\/10.1016\/j.cell.2025.12.019 (2026).","journal-title":"Cell"},{"key":"979_CR31","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.molcel.2015.01.011","volume":"57","author":"E Hatchi","year":"2015","unstructured":"Hatchi, E. et al. BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol. Cell 57, 636\u2013647 https:\/\/doi.org\/10.1016\/j.molcel.2015.01.011 (2015).","journal-title":"Mol. Cell"},{"key":"979_CR32","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nature13374","volume":"511","author":"V Bhatia","year":"2014","unstructured":"Bhatia, V. et al. BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature 511, 362\u2013365 https:\/\/doi.org\/10.1038\/nature13374 (2014).","journal-title":"Nature"},{"key":"979_CR33","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.celrep.2017.12.086","volume":"22","author":"MKK Shivji","year":"2018","unstructured":"Shivji, M. K. K., Renaudin, X., Williams, C. H. & Venkitaraman, A. R. BRCA2 regulates transcription elongation by RNA polymerase II to prevent R-loop accumulation. Cell Rep. 22, 1031\u20131039 https:\/\/doi.org\/10.1016\/j.celrep.2017.12.086 (2018).","journal-title":"Cell Rep."},{"key":"979_CR34","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1158\/0008-5472.CAN-17-3970","volume":"78","author":"HD Nguyen","year":"2018","unstructured":"Nguyen, H. D. et al. Spliceosome mutations induce R loop-associated sensitivity to ATR inhibition in myelodysplastic syndromes. Cancer Res. 78, 5363\u20135374 https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3970 (2018).","journal-title":"Cancer Res."},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.molcel.2017.12.029","volume":"69","author":"L Chen","year":"2018","unstructured":"Chen, L. et al. The augmented R-loop is a unifying mechanism for myelodysplastic syndromes induced by high-risk splicing factor mutations. Mol. Cell 69, 412\u2013425.e6 https:\/\/doi.org\/10.1016\/j.molcel.2017.12.029 (2018).","journal-title":"Mol. Cell"},{"key":"979_CR36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nature25748","volume":"555","author":"A Gorthi","year":"2018","unstructured":"Gorthi, A. et al. EWS\u2013FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma. Nature 555, 387\u2013391 https:\/\/doi.org\/10.1038\/nature25748 (2018).","journal-title":"Nature"},{"key":"979_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08905-8","volume":"10","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. G-quadruplex DNA drives genomic instability and represents a targetable molecular abnormality in ATRX-deficient malignant glioma. Nat. Commun. 10, 943 https:\/\/doi.org\/10.1038\/s41467-019-08905-8 (2019).","journal-title":"Nat. Commun."},{"key":"979_CR38","doi-asserted-by":"publisher","first-page":"9936","DOI":"10.1073\/pnas.0804510105","volume":"105","author":"I Voineagu","year":"2008","unstructured":"Voineagu, I., Narayanan, V., Lobachev, K. S. & Mirkin, S. M. Replication stalling at unstable inverted repeats: interplay between DNA hairpins and fork stabilizing proteins. Proc. Natl Acad. Sci. USA 105, 9936\u20139941 https:\/\/doi.org\/10.1073\/pnas.0804510105 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR39","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41586-020-2769-8","volume":"586","author":"N van Wietmarschen","year":"2020","unstructured":"van Wietmarschen, N. et al. Repeat expansions confer WRN dependence in microsatellite-unstable cancers. Nature 586, 292\u2013298 https:\/\/doi.org\/10.1038\/s41586-020-2769-8 (2020). This study reveals that large-scale TA-dinucleotide repeat expansions in MSI cancers form non-B DNA secondary structures that stall replication forks, creating a specific reliance on the WRN helicase to unwind these structures and prevent fatal chromosome shattering.","journal-title":"Nature"},{"key":"979_CR40","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1158\/0008-5472.CAN-20-1744","volume":"80","author":"M Gupta","year":"2020","unstructured":"Gupta, M. et al. BRG1 loss predisposes lung cancers to replicative stress and ATR dependency. Cancer Res. 80, 3841\u20133854 https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1744 (2020).","journal-title":"Cancer Res."},{"key":"979_CR41","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1038\/s41588-021-00867-2","volume":"53","author":"A Bayona-Feliu","year":"2021","unstructured":"Bayona-Feliu, A., Barroso, S., Munoz, S. & Aguilera, A. The SWI\/SNF chromatin remodeling complex helps resolve R-loop-mediated transcription\u2013replication conflicts. Nat. Genet. 53, 1050\u20131063 https:\/\/doi.org\/10.1038\/s41588-021-00867-2 (2021).","journal-title":"Nat. Genet."},{"key":"979_CR42","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1016\/j.molcel.2023.05.026","volume":"83","author":"JM Schvartzman","year":"2023","unstructured":"Schvartzman, J. M. et al. Oncogenic IDH mutations increase heterochromatin-related replication stress without impacting homologous recombination. Mol. Cell 83, 2347\u20132356.e8 https:\/\/doi.org\/10.1016\/j.molcel.2023.05.026 (2023).","journal-title":"Mol. Cell"},{"key":"979_CR43","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201796659","volume":"38","author":"F Li","year":"2019","unstructured":"Li, F. et al. ATRX loss induces telomere dysfunction and necessitates induction of alternative lengthening of telomeres during human cell immortalization. EMBO J. 38, e96659 https:\/\/doi.org\/10.15252\/embj.201796659 (2019).","journal-title":"EMBO J."},{"key":"979_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41568-023-00557-7","volume":"23","author":"NJ Mullen","year":"2023","unstructured":"Mullen, N. J. & Singh, P. K. Nucleotide metabolism: a pan-cancer metabolic dependency. Nat. Rev. Cancer 23, 275\u2013294 https:\/\/doi.org\/10.1038\/s41568-023-00557-7 (2023).","journal-title":"Nat. Rev. Cancer"},{"key":"979_CR45","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.cell.2013.10.043","volume":"155","author":"LI Toledo","year":"2013","unstructured":"Toledo, L. I. et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell 155, 1088\u20131103 https:\/\/doi.org\/10.1016\/j.cell.2013.10.043 (2013). This report shows that ATR inhibition in cells under high replication stress leads to cell death through replication catastrophe.","journal-title":"Cell"},{"key":"979_CR46","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.celrep.2013.03.004","volume":"3","author":"KM Aird","year":"2013","unstructured":"Aird, K. M. et al. Suppression of nucleotide metabolism underlies the establishment and maintenance of oncogene-induced senescence. Cell Rep. 3, 1252\u20131265 https:\/\/doi.org\/10.1016\/j.celrep.2013.03.004 (2013).","journal-title":"Cell Rep."},{"key":"979_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41586-018-0050-1","volume":"557","author":"F Coquel","year":"2018","unstructured":"Coquel, F. et al. SAMHD1 acts at stalled replication forks to prevent interferon induction. Nature 557, 57\u201361 https:\/\/doi.org\/10.1038\/s41586-018-0050-1 (2018).","journal-title":"Nature"},{"key":"979_CR48","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1182\/blood-2013-04-490847","volume":"123","author":"R Clifford","year":"2014","unstructured":"Clifford, R. et al. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 123, 1021\u20131031 https:\/\/doi.org\/10.1182\/blood-2013-04-490847 (2014).","journal-title":"Blood"},{"key":"979_CR49","doi-asserted-by":"publisher","first-page":"4723","DOI":"10.1073\/pnas.1519128113","volume":"113","author":"M Rentoft","year":"2016","unstructured":"Rentoft, M. et al. Heterozygous colon cancer-associated mutations of SAMHD1 have functional significance. Proc. Natl Acad. Sci. USA 113, 4723\u20134728 https:\/\/doi.org\/10.1073\/pnas.1519128113 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR50","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1073\/pnas.94.7.3290","volume":"94","author":"BC Blount","year":"1997","unstructured":"Blount, B. C. et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc. Natl Acad. Sci. USA 94, 3290\u20133295 https:\/\/doi.org\/10.1073\/pnas.94.7.3290 (1997).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR51","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1016\/j.molcel.2024.04.004","volume":"84","author":"S Saxena","year":"2024","unstructured":"Saxena, S. et al. Unprocessed genomic uracil as a source of DNA replication stress in cancer cells. Mol. Cell 84, 2036\u20132052.e7 https:\/\/doi.org\/10.1016\/j.molcel.2024.04.004 (2024).","journal-title":"Mol. Cell"},{"key":"979_CR52","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1016\/j.molcel.2025.04.015","volume":"85","author":"O Mortusewicz","year":"2025","unstructured":"Mortusewicz, O., Haslam, J., Gad, H. & Helleday, T. Uracil-induced replication stress drives mutations, genome instability, anti-cancer treatment efficacy, and resistance. Mol. Cell 85, 1897\u20131906 https:\/\/doi.org\/10.1016\/j.molcel.2025.04.015 (2025).","journal-title":"Mol. Cell"},{"key":"979_CR53","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10409238.2020.1869175","volume":"56","author":"ZX Zhou","year":"2021","unstructured":"Zhou, Z. X., Williams, J. S., Lujan, S. A. & Kunkel, T. A. Ribonucleotide incorporation into DNA during DNA replication and its consequences. Crit. Rev. Biochem. Mol. Biol. 56, 109\u2013124 https:\/\/doi.org\/10.1080\/10409238.2020.1869175 (2021).","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"979_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.tibs.2023.11.001","volume":"49","author":"KW Caldecott","year":"2024","unstructured":"Caldecott, K. W. Causes and consequences of DNA single-strand breaks. Trends Biochem. Sci. 49, 68\u201378 https:\/\/doi.org\/10.1016\/j.tibs.2023.11.001 (2024).","journal-title":"Trends Biochem. Sci."},{"key":"979_CR55","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41594-022-00747-1","volume":"29","author":"A Vaitsiankova","year":"2022","unstructured":"Vaitsiankova, A. et al. PARP inhibition impedes the maturation of nascent DNA strands during DNA replication. Nat. Struct. Mol. Biol. 29, 329\u2013338 https:\/\/doi.org\/10.1038\/s41594-022-00747-1 (2022).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"979_CR56","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gad.348479.121","volume":"35","author":"A Simoneau","year":"2021","unstructured":"Simoneau, A., Xiong, R. & Zou, L. The trans cell cycle effects of PARP inhibitors underlie their selectivity toward BRCA1\/2-deficient cells. Genes Dev. 35, 1271\u20131289 https:\/\/doi.org\/10.1101\/gad.348479.121 (2021). This study shows that ssDNA gaps are a key determinant of PARP inhibitor sensitivity in BRCA-deficient cells.","journal-title":"Genes Dev."},{"key":"979_CR57","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad033","volume":"5","author":"JD Strauss","year":"2023","unstructured":"Strauss, J. D. & Pursell, Z. F. Replication DNA polymerases, genome instability and cancer therapies. NAR Cancer 5, zcad033 https:\/\/doi.org\/10.1093\/narcan\/zcad033 (2023).","journal-title":"NAR Cancer"},{"key":"979_CR58","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.32692","volume":"7","author":"KP Hodel","year":"2018","unstructured":"Hodel, K. P. et al. Explosive mutation accumulation triggered by heterozygous human Pol \u03b5 proofreading-deficiency is driven by suppression of mismatch repair. eLife 7, e32692 https:\/\/doi.org\/10.7554\/eLife.32692 (2018).","journal-title":"eLife"},{"key":"979_CR59","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad011","volume":"5","author":"G Labrousse","year":"2023","unstructured":"Labrousse, G. et al. The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity. NAR Cancer 5, zcad011 https:\/\/doi.org\/10.1093\/narcan\/zcad011 (2023).","journal-title":"NAR Cancer"},{"key":"979_CR60","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1158\/1541-7786.MCR-10-0161","volume":"8","author":"CS Hass","year":"2010","unstructured":"Hass, C. S., Gakhar, L. & Wold, M. S. Functional characterization of a cancer causing mutation in human replication protein A. Mol. Cancer Res. 8, 1017\u20131026 https:\/\/doi.org\/10.1158\/1541-7786.MCR-10-0161 (2010).","journal-title":"Mol. Cancer Res."},{"key":"979_CR61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jb\/mvw065","volume":"161","author":"R Tatsumi","year":"2017","unstructured":"Tatsumi, R. & Ishimi, Y. An MCM4 mutation detected in cancer cells affects MCM4\/6\/7 complex formation. J. Biochem. 161, 259\u2013268 https:\/\/doi.org\/10.1093\/jb\/mvw065 (2017).","journal-title":"J. Biochem."},{"key":"979_CR62","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature25507","volume":"555","author":"M Macheret","year":"2018","unstructured":"Macheret, M. & Halazonetis, T. D. Intragenic origins due to short G1 phases underlie oncogene-induced DNA replication stress. Nature 555, 112\u2013116 https:\/\/doi.org\/10.1038\/nature25507 (2018).","journal-title":"Nature"},{"key":"979_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1101\/gad.1495007","volume":"21","author":"YJ Machida","year":"2007","unstructured":"Machida, Y. J. & Dutta, A. The APC\/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 21, 184\u2013194 https:\/\/doi.org\/10.1101\/gad.1495007 (2007).","journal-title":"Genes Dev."},{"key":"979_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13674-5","volume":"10","author":"O Brison","year":"2019","unstructured":"Brison, O. et al. Transcription-mediated organization of the replication initiation program across large genes sets common fragile sites genome-wide. Nat. Commun. 10, 5693 https:\/\/doi.org\/10.1038\/s41467-019-13674-5 (2019).","journal-title":"Nat. Commun."},{"key":"979_CR65","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-biochem-062917-012405","volume":"87","author":"W Yang","year":"2018","unstructured":"Yang, W. & Gao, Y. Translesion and repair DNA polymerases: diverse structure and mechanism. Annu. Rev. Biochem. 87, 239\u2013261 https:\/\/doi.org\/10.1146\/annurev-biochem-062917-012405 (2018).","journal-title":"Annu. Rev. Biochem."},{"key":"979_CR66","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1038\/21447","volume":"399","author":"C Masutani","year":"1999","unstructured":"Masutani, C. et al. The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399, 700\u2013704 https:\/\/doi.org\/10.1038\/21447 (1999).","journal-title":"Nature"},{"key":"979_CR67","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi, R., Sarangi, P. & D\u2019Andrea, A. D. The Fanconi anaemia pathway: new players and new functions. Nat. Rev. Mol. Cell Biol. 17, 337\u2013349 https:\/\/doi.org\/10.1038\/nrm.2016.48 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"979_CR68","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nrm3935","volume":"16","author":"KJ Neelsen","year":"2015","unstructured":"Neelsen, K. J. & Lopes, M. Replication fork reversal in eukaryotes: from dead end to dynamic response. Nat. Rev. Mol. Cell Biol. 16, 207\u2013220 https:\/\/doi.org\/10.1038\/nrm3935 (2015).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"979_CR69","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.cell.2011.03.041","volume":"145","author":"K Schlacher","year":"2011","unstructured":"Schlacher, K. et al. Double-strand break repair-independent role for BRCA2 in blocking stalled replication fork degradation by MRE11. Cell 145, 529\u2013542 https:\/\/doi.org\/10.1016\/j.cell.2011.03.041 (2011). This paper reveals that BRCA2-deficient cells fail to protect stalled replication forks and make nascent DNA vulnerable to nucleolytic degradation.","journal-title":"Cell"},{"key":"979_CR70","doi-asserted-by":"publisher","first-page":"4026","DOI":"10.1016\/j.molcel.2021.09.013","volume":"81","author":"S Tirman","year":"2021","unstructured":"Tirman, S. et al. Temporally distinct post-replicative repair mechanisms fill PRIMPOL-dependent ssDNA gaps in human cells. Mol. Cell 81, 4026\u20134040.e8 https:\/\/doi.org\/10.1016\/j.molcel.2021.09.013 (2021).","journal-title":"Mol. Cell"},{"key":"979_CR71","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1101\/gad.352421.124","volume":"39","author":"IM Seppa","year":"2025","unstructured":"Seppa, I. M. et al. MRN-CtIP, EXO1, and DNA2-WRN\/BLM act bidirectionally to process DNA gaps in PARPi-treated cells without strand cleavage. Genes Dev. 39, 582\u2013602 https:\/\/doi.org\/10.1101\/gad.352421.124 (2025).","journal-title":"Genes Dev."},{"key":"979_CR72","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1016\/j.molcel.2021.08.016","volume":"81","author":"A Taglialatela","year":"2021","unstructured":"Taglialatela, A. et al. REV1-Pol\u03b6 maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps. Mol. Cell 81, 4008\u20134025.e7 https:\/\/doi.org\/10.1016\/j.molcel.2021.08.016 (2021).","journal-title":"Mol. Cell"},{"key":"979_CR73","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1016\/j.molcel.2021.06.011","volume":"81","author":"K Cong","year":"2021","unstructured":"Cong, K. et al. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency. Mol. Cell 81, 3128\u20133144.e7 https:\/\/doi.org\/10.1016\/j.molcel.2021.06.011 (2021). This study suggests that ssDNA accumulation in BRCA-deficient cells underlies PARP inhibitor sensitivity.","journal-title":"Mol. Cell"},{"key":"979_CR74","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1158\/0008-5472.CAN-18-0633","volume":"78","author":"R Ali","year":"2018","unstructured":"Ali, R. et al. Targeting PARP1 in XRCC1-deficient sporadic invasive breast cancer or preinvasive ductal carcinoma in situ induces synthetic lethality and chemoprevention. Cancer Res. 78, 6818\u20136827 https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0633 (2018).","journal-title":"Cancer Res."},{"key":"979_CR75","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1158\/0008-5472.CAN-13-3229","volume":"74","author":"KN Mohni","year":"2014","unstructured":"Mohni, K. N., Kavanaugh, G. M. & Cortez, D. ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency. Cancer Res. 74, 2835\u20132845 https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-3229 (2014).","journal-title":"Cancer Res."},{"key":"979_CR76","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcac045","volume":"5","author":"JR Heyza","year":"2023","unstructured":"Heyza, J. R. et al. ATR inhibition overcomes platinum tolerance associated with ERCC1- and p53-deficiency by inducing replication catastrophe. NAR Cancer 5, zcac045 https:\/\/doi.org\/10.1093\/narcan\/zcac045 (2023).","journal-title":"NAR Cancer"},{"key":"979_CR77","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/363558a0","volume":"363","author":"Y Ionov","year":"1993","unstructured":"Ionov, Y., Peinado, M. A., Malkhosyan, S., Shibata, D. & Perucho, M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558\u2013561 https:\/\/doi.org\/10.1038\/363558a0 (1993).","journal-title":"Nature"},{"key":"979_CR78","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1126\/science.abb4542","volume":"372","author":"K Fugger","year":"2021","unstructured":"Fugger, K. et al. Targeting the nucleotide salvage factor DNPH1 sensitizes BRCA-deficient cells to PARP inhibitors. Science 372, 156\u2013165 https:\/\/doi.org\/10.1126\/science.abb4542 (2021).","journal-title":"Science"},{"key":"979_CR79","doi-asserted-by":"publisher","unstructured":"Ortega, P. et al. Mechanism of DNA replication fork breakage and PARP1 hyperactivation during replication catastrophe. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.adu0437 (2025).","DOI":"10.1126\/sciadv.adu0437"},{"key":"979_CR80","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64578-6","volume":"16","author":"K Situ","year":"2025","unstructured":"Situ, K. et al. BRCA2 deficiency and replication stress drive APOBEC3-mediated genomic instability. Nat. Commun. 16, 9544 https:\/\/doi.org\/10.1038\/s41467-025-64578-6 (2025).","journal-title":"Nat. Commun."},{"key":"979_CR81","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1101\/gad.214080.113","volume":"27","author":"FB Couch","year":"2013","unstructured":"Couch, F. B. et al. ATR phosphorylates SMARCAL1 to prevent replication fork collapse. Genes Dev. 27, 1610\u20131623 https:\/\/doi.org\/10.1101\/gad.214080.113 (2013).","journal-title":"Genes Dev."},{"key":"979_CR82","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1101\/gad.223180.113","volume":"27","author":"RL Ragland","year":"2013","unstructured":"Ragland, R. L. et al. RNF4 and PLK1 are required for replication fork collapse in ATR-deficient cells. Genes Dev. 27, 2259\u20132273 https:\/\/doi.org\/10.1101\/gad.223180.113 (2013).","journal-title":"Genes Dev."},{"key":"979_CR83","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.molcel.2019.10.010","volume":"77","author":"DA Matos","year":"2020","unstructured":"Matos, D. A. et al. ATR protects the genome against R loops through a MUS81-triggered feedback loop. Mol. Cell 77, 514\u2013527.e4 https:\/\/doi.org\/10.1016\/j.molcel.2019.10.010 (2020).","journal-title":"Mol. Cell"},{"key":"979_CR84","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1146\/annurev-cancerbio-030617-050502","volume":"2","author":"CC Chen","year":"2018","unstructured":"Chen, C. C., Feng, W., Lim, P. X., Kass, E. M. & Jasin, M. Homology-directed repair and the role of BRCA1, BRCA2, and related proteins in genome integrity and cancer. Annu. Rev. Cancer Biol. 2, 313\u2013336 https:\/\/doi.org\/10.1146\/annurev-cancerbio-030617-050502 (2018).","journal-title":"Annu. Rev. Cancer Biol."},{"key":"979_CR85","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrm.2017.67","volume":"18","author":"JC Saldivar","year":"2017","unstructured":"Saldivar, J. C., Cortez, D. & Cimprich, K. A. The essential kinase ATR: ensuring faithful duplication of a challenging genome. Nat. Rev. Mol. Cell Biol. 18, 622\u2013636 https:\/\/doi.org\/10.1038\/nrm.2017.67 (2017).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"979_CR86","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.cell.2005.12.041","volume":"124","author":"A Kumagai","year":"2006","unstructured":"Kumagai, A., Lee, J., Yoo, H. Y. & Dunphy, W. G. TopBP1 activates the ATR\u2013ATRIP complex. Cell 124, 943\u2013955 https:\/\/doi.org\/10.1016\/j.cell.2005.12.041 (2006).","journal-title":"Cell"},{"key":"979_CR87","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/ncb3415","volume":"18","author":"TE Bass","year":"2016","unstructured":"Bass, T. E. et al. ETAA1 acts at stalled replication forks to maintain genome integrity. Nat. Cell Biol. 18, 1185\u20131195 https:\/\/doi.org\/10.1038\/ncb3415 (2016).","journal-title":"Nat. Cell Biol."},{"key":"979_CR88","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/ncb3422","volume":"18","author":"P Haahr","year":"2016","unstructured":"Haahr, P. et al. Activation of the ATR kinase by the RPA-binding protein ETAA1. Nat. Cell Biol. 18, 1196\u20131207 https:\/\/doi.org\/10.1038\/ncb3422 (2016).","journal-title":"Nat. Cell Biol."},{"key":"979_CR89","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1016\/j.cub.2016.10.030","volume":"26","author":"YC Lee","year":"2016","unstructured":"Lee, Y. C., Zhou, Q., Chen, J. & Yuan, J. RPA-binding protein ETAA1 is an ATR activator involved in DNA replication stress response. Curr. Biol. 26, 3257\u20133268 https:\/\/doi.org\/10.1016\/j.cub.2016.10.030 (2016).","journal-title":"Curr. Biol."},{"key":"979_CR90","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1126\/science.aap9346","volume":"361","author":"JC Saldivar","year":"2018","unstructured":"Saldivar, J. C. et al. An intrinsic S\/G2 checkpoint enforced by ATR. Science 361, 806\u2013810 https:\/\/doi.org\/10.1126\/science.aap9346 (2018).","journal-title":"Science"},{"key":"979_CR91","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1083\/jcb.201810058","volume":"218","author":"TE Bass","year":"2019","unstructured":"Bass, T. E. & Cortez, D. Quantitative phosphoproteomics reveals mitotic function of the ATR activator ETAA1. J. Cell Biol. 218, 1235\u20131249 https:\/\/doi.org\/10.1083\/jcb.201810058 (2019).","journal-title":"J. Cell Biol."},{"key":"979_CR92","doi-asserted-by":"publisher","first-page":"49599","DOI":"10.1074\/jbc.M408353200","volume":"279","author":"A Kumagai","year":"2004","unstructured":"Kumagai, A., Kim, S. M. & Dunphy, W. G. Claspin and the activated form of ATR\u2013ATRIP collaborate in the activation of Chk1. J. Biol. Chem. 279, 49599\u201349608 https:\/\/doi.org\/10.1074\/jbc.M408353200 (2004).","journal-title":"J. Biol. Chem."},{"key":"979_CR93","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.molcel.2015.06.026","volume":"59","author":"K Burdova","year":"2015","unstructured":"Burdova, K., Mihaljevic, B., Sturzenegger, A., Chappidi, N. & Janscak, P. The mismatch-binding factor MutS\u03b2 can mediate ATR activation in response to DNA double-strand breaks. Mol. Cell 59, 603\u2013614 https:\/\/doi.org\/10.1016\/j.molcel.2015.06.026 (2015).","journal-title":"Mol. Cell"},{"key":"979_CR94","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1091\/mbc.e08-12-1190","volume":"20","author":"HY Yoo","year":"2009","unstructured":"Yoo, H. Y., Kumagai, A., Shevchenko, A., Shevchenko, A. & Dunphy, W. G. The Mre11\u2013Rad50\u2013Nbs1 complex mediates activation of TopBP1 by ATM. Mol. Biol. Cell 20, 2351\u20132360 https:\/\/doi.org\/10.1091\/mbc.e08-12-1190 (2009).","journal-title":"Mol. Biol. Cell"},{"key":"979_CR95","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1091\/mbc.E13-01-0025","volume":"24","author":"J Lee","year":"2013","unstructured":"Lee, J. & Dunphy, W. G. The Mre11\u2013Rad50\u2013Nbs1 (MRN) complex has a specific role in the activation of Chk1 in response to stalled replication forks. Mol. Biol. Cell 24, 1343\u20131353 https:\/\/doi.org\/10.1091\/mbc.E13-01-0025 (2013).","journal-title":"Mol. Biol. Cell"},{"key":"979_CR96","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.molcel.2013.03.006","volume":"50","author":"AM Duursma","year":"2013","unstructured":"Duursma, A. M., Driscoll, R., Elias, J. E. & Cimprich, K. A. A role for the MRN complex in ATR activation via TOPBP1 recruitment. Mol. Cell 50, 116\u2013122 https:\/\/doi.org\/10.1016\/j.molcel.2013.03.006 (2013).","journal-title":"Mol. Cell"},{"key":"979_CR97","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.celrep.2013.04.018","volume":"3","author":"B Shiotani","year":"2013","unstructured":"Shiotani, B. et al. Two distinct modes of ATR activation orchestrated by Rad17 and Nbs1. Cell Rep. 3, 1651\u20131662 https:\/\/doi.org\/10.1016\/j.celrep.2013.04.018 (2013).","journal-title":"Cell Rep."},{"key":"979_CR98","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1083\/jcb.201010026","volume":"193","author":"J Wang","year":"2011","unstructured":"Wang, J., Gong, Z. & Chen, J. MDC1 collaborates with TopBP1 in DNA replication checkpoint control. J. Cell Biol. 193, 267\u2013273 https:\/\/doi.org\/10.1083\/jcb.201010026 (2011).","journal-title":"J. Cell Biol."},{"key":"979_CR99","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1126\/science.1140321","volume":"316","author":"S Matsuoka","year":"2007","unstructured":"Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160\u20131166 https:\/\/doi.org\/10.1126\/science.1140321 (2007). This proteomic study identifies hundreds of potential substrates of ATM and ATR induced by DNA damage or replication stress.","journal-title":"Science"},{"key":"979_CR100","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1101\/gad.14.12.1448","volume":"14","author":"Q Liu","year":"2000","unstructured":"Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G2\/M DNA damage checkpoint. Genes Dev. 14, 1448\u20131459 (2000).","journal-title":"Genes Dev."},{"key":"979_CR101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1083\/jcb.200510130","volume":"173","author":"S Bekker-Jensen","year":"2006","unstructured":"Bekker-Jensen, S. et al. Spatial organization of the mammalian genome surveillance machinery in response to DNA strand breaks. J. Cell Biol. 173, 195\u2013206 https:\/\/doi.org\/10.1083\/jcb.200510130 (2006).","journal-title":"J. Cell Biol."},{"key":"979_CR102","doi-asserted-by":"publisher","first-page":"10389","DOI":"10.1073\/pnas.190030497","volume":"97","author":"S Matsuoka","year":"2000","unstructured":"Matsuoka, S. et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. Proc. Natl Acad. Sci. USA 97, 10389\u201310394 https:\/\/doi.org\/10.1073\/pnas.190030497 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR103","doi-asserted-by":"publisher","first-page":"5775","DOI":"10.1038\/sj.emboj.7601446","volume":"25","author":"T Stiff","year":"2006","unstructured":"Stiff, T. et al. ATR-dependent phosphorylation and activation of ATM in response to UV treatment or replication fork stalling. EMBO J. 25, 5775\u20135782 https:\/\/doi.org\/10.1038\/sj.emboj.7601446 (2006).","journal-title":"EMBO J."},{"key":"979_CR104","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.molcel.2015.07.029","volume":"59","author":"R Buisson","year":"2015","unstructured":"Buisson, R., Boisvert, J. L., Benes, C. H. & Zou, L. Distinct but concerted roles of ATR, DNA-PK, and Chk1 in countering replication stress during S phase. Mol. Cell 59, 1011\u20131024 https:\/\/doi.org\/10.1016\/j.molcel.2015.07.029 (2015).","journal-title":"Mol. Cell"},{"key":"979_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112792","volume":"42","author":"W Leung","year":"2023","unstructured":"Leung, W. et al. ATR protects ongoing and newly assembled DNA replication forks through distinct mechanisms. Cell Rep. 42, 112792 https:\/\/doi.org\/10.1016\/j.celrep.2023.112792 (2023).","journal-title":"Cell Rep."},{"key":"979_CR106","doi-asserted-by":"publisher","first-page":"13374","DOI":"10.1073\/pnas.1903418116","volume":"116","author":"TN Moiseeva","year":"2019","unstructured":"Moiseeva, T. N. et al. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proc. Natl Acad. Sci. USA 116, 13374\u201313383 https:\/\/doi.org\/10.1073\/pnas.1903418116 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR107","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.molcel.2008.10.014","volume":"32","author":"SJ Collis","year":"2008","unstructured":"Collis, S. J. et al. FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex. Mol. Cell 32, 313\u2013324 https:\/\/doi.org\/10.1016\/j.molcel.2008.10.014 (2008).","journal-title":"Mol. Cell"},{"key":"979_CR108","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/sj.emboj.7600113","volume":"23","author":"P Pichierri","year":"2004","unstructured":"Pichierri, P. & Rosselli, F. The DNA crosslink-induced S-phase checkpoint depends on ATR\u2013CHK1 and ATR\u2013NBS1\u2013FANCD2 pathways. EMBO J. 23, 1178\u20131187 https:\/\/doi.org\/10.1038\/sj.emboj.7600113 (2004).","journal-title":"EMBO J."},{"key":"979_CR109","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1172\/JCI122622","volume":"129","author":"AB Bukhari","year":"2019","unstructured":"Bukhari, A. B. et al. Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis. J. Clin. Invest. 129, 1329\u20131344 https:\/\/doi.org\/10.1172\/JCI122622 (2019).","journal-title":"J. Clin. Invest."},{"key":"979_CR110","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1128\/MCB.22.4.1049-1059.2002","volume":"22","author":"B Xu","year":"2002","unstructured":"Xu, B., Kim, S. T., Lim, D. S. & Kastan, M. B. Two molecularly distinct G2\/M checkpoints are induced by ionizing irradiation. Mol. Cell Biol. 22, 1049\u20131059 https:\/\/doi.org\/10.1128\/MCB.22.4.1049-1059.2002 (2002).","journal-title":"Mol. Cell Biol."},{"key":"979_CR111","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1158\/1535-7163.MCT-22-0685","volume":"22","author":"A Turchick","year":"2023","unstructured":"Turchick, A. et al. Selective inhibition of ATM-dependent double-strand break repair and checkpoint control synergistically enhances the efficacy of ATR inhibitors. Mol. Cancer Ther. 22, 859\u2013872 https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0685 (2023).","journal-title":"Mol. Cancer Ther."},{"key":"979_CR112","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/s41556-026-01931-x","volume":"28","author":"Y Song","year":"2026","unstructured":"Song, Y. et al. ATM counteracts chromatin-bound cGAS during DNA replication. Nat. Cell Biol. 28, 946\u2013956 https:\/\/doi.org\/10.1038\/s41556-026-01931-x (2026).","journal-title":"Nat. Cell Biol."},{"key":"979_CR113","doi-asserted-by":"publisher","first-page":"20792","DOI":"10.1073\/pnas.1011412107","volume":"107","author":"K Xie","year":"2010","unstructured":"Xie, K., Doles, J., Hemann, M. T. & Walker, G. C. Error-prone translesion synthesis mediates acquired chemoresistance. Proc. Natl Acad. Sci. USA 107, 20792\u201320797 https:\/\/doi.org\/10.1073\/pnas.1011412107 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR114","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abn1229","volume":"8","author":"M Stanzione","year":"2022","unstructured":"Stanzione, M. et al. Translesion DNA synthesis mediates acquired resistance to olaparib plus temozolomide in small cell lung cancer. Sci. Adv. 8, eabn1229 https:\/\/doi.org\/10.1126\/sciadv.abn1229 (2022).","journal-title":"Sci. Adv."},{"key":"979_CR115","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.molcel.2013.09.025","volume":"52","author":"S Garcia-Gomez","year":"2013","unstructured":"Garcia-Gomez, S. et al. PrimPol, an archaic primase\/polymerase operating in human cells. Mol. Cell 52, 541\u2013553 https:\/\/doi.org\/10.1016\/j.molcel.2013.09.025 (2013).","journal-title":"Mol. Cell"},{"key":"979_CR116","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nsmb.2719","volume":"20","author":"S Mouron","year":"2013","unstructured":"Mouron, S. et al. Repriming of DNA synthesis at stalled replication forks by human PrimPol. Nat. Struct. Mol. Biol. 20, 1383\u20131389 https:\/\/doi.org\/10.1038\/nsmb.2719 (2013).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"979_CR117","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.molcel.2019.10.008","volume":"77","author":"A Quinet","year":"2020","unstructured":"Quinet, A. et al. PRIMPOL-mediated adaptive response suppresses replication fork reversal in BRCA-deficient cells. Mol. Cell 77, 461\u2013474.e9 https:\/\/doi.org\/10.1016\/j.molcel.2019.10.008 (2020).","journal-title":"Mol. Cell"},{"key":"979_CR118","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adk2771","volume":"10","author":"AS Kawale","year":"2024","unstructured":"Kawale, A. S. et al. APOBEC3A induces DNA gaps through PRIMPOL and confers gap-associated therapeutic vulnerability. Sci. Adv. 10, eadk2771 https:\/\/doi.org\/10.1126\/sciadv.adk2771 (2024).","journal-title":"Sci. Adv."},{"key":"979_CR119","doi-asserted-by":"publisher","first-page":"4664","DOI":"10.1016\/j.molcel.2022.11.008","volume":"82","author":"O Belan","year":"2022","unstructured":"Belan, O. et al. POLQ seals post-replicative ssDNA gaps to maintain genome stability in BRCA-deficient cancer cells. Mol. Cell 82, 4664\u20134680.e9 https:\/\/doi.org\/10.1016\/j.molcel.2022.11.008 (2022).","journal-title":"Mol. Cell"},{"key":"979_CR120","doi-asserted-by":"publisher","DOI":"10.1126\/science.ado3867","volume":"385","author":"R Pavani","year":"2024","unstructured":"Pavani, R. et al. Structure and repair of replication-coupled DNA breaks. Science 385, eado3867 https:\/\/doi.org\/10.1126\/science.ado3867 (2024).","journal-title":"Science"},{"key":"979_CR121","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.molcel.2024.11.006","volume":"85","author":"R Elango","year":"2025","unstructured":"Elango, R. et al. Two-ended recombination at a Flp-nickase-broken replication fork. Mol. Cell 85, 78\u201390.e3 https:\/\/doi.org\/10.1016\/j.molcel.2024.11.006 (2025).","journal-title":"Mol. Cell"},{"key":"979_CR122","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.gde.2021.08.002","volume":"71","author":"X Wu","year":"2021","unstructured":"Wu, X. & Malkova, A. Break-induced replication mechanisms in yeast and mammals. Curr. Opin. Genet. Dev. 71, 163\u2013170 https:\/\/doi.org\/10.1016\/j.gde.2021.08.002 (2021).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"979_CR123","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1126\/science.1243211","volume":"343","author":"L Costantino","year":"2014","unstructured":"Costantino, L. et al. Break-induced replication repair of damaged forks induces genomic duplications in human cells. Science 343, 88\u201391 https:\/\/doi.org\/10.1126\/science.1243211 (2014).","journal-title":"Science"},{"key":"979_CR124","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ncb1212","volume":"7","author":"CS Sorensen","year":"2005","unstructured":"Sorensen, C. S. et al. The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair. Nat. Cell Biol. 7, 195\u2013201 https:\/\/doi.org\/10.1038\/ncb1212 (2005).","journal-title":"Nat. Cell Biol."},{"key":"979_CR125","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm0314","volume":"8","author":"KPM Mehta","year":"2022","unstructured":"Mehta, K. P. M. et al. CHK1 phosphorylates PRIMPOL to promote replication stress tolerance. Sci. Adv. 8, eabm0314 https:\/\/doi.org\/10.1126\/sciadv.abm0314 (2022).","journal-title":"Sci. Adv."},{"key":"979_CR126","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/s41571-024-00863-5","volume":"21","author":"NYL Ngoi","year":"2024","unstructured":"Ngoi, N. Y. L. et al. Targeting ATR in patients with cancer. Nat. Rev. Clin. Oncol. 21, 278\u2013293 https:\/\/doi.org\/10.1038\/s41571-024-00863-5 (2024).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"979_CR127","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/ncb1882","volume":"11","author":"KL Chan","year":"2009","unstructured":"Chan, K. L., Palmai-Pallag, T., Ying, S. & Hickson, I. D. Replication stress induces sister-chromatid bridging at fragile site loci in mitosis. Nat. Cell Biol. 11, 753\u2013760 https:\/\/doi.org\/10.1038\/ncb1882 (2009).","journal-title":"Nat. Cell Biol."},{"key":"979_CR128","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1083\/jcb.201011083","volume":"193","author":"JA Harrigan","year":"2011","unstructured":"Harrigan, J. A. et al. Replication stress induces 53BP1-containing OPT domains in G1 cells. J. Cell Biol. 193, 97\u2013108 https:\/\/doi.org\/10.1083\/jcb.201011083 (2011).","journal-title":"J. Cell Biol."},{"key":"979_CR129","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/nature16139","volume":"528","author":"S Minocherhomji","year":"2015","unstructured":"Minocherhomji, S. et al. Replication stress activates DNA repair synthesis in mitosis. Nature 528, 286\u2013290 https:\/\/doi.org\/10.1038\/nature16139 (2015). This paper demonstrates that entry into early mitosis triggers DNA synthesis at under-replicated regions, mitigating chromosome mis-segregation and genomic instability caused by replication stress.","journal-title":"Nature"},{"key":"979_CR130","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.molcel.2016.10.037","volume":"64","author":"R Bhowmick","year":"2016","unstructured":"Bhowmick, R., Minocherhomji, S. & Hickson, I. D. RAD52 facilitates mitotic DNA synthesis following replication stress. Mol. Cell 64, 1117\u20131126 https:\/\/doi.org\/10.1016\/j.molcel.2016.10.037 (2016).","journal-title":"Mol. Cell"},{"key":"979_CR131","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/BF00272988","volume":"67","author":"TW Glover","year":"1984","unstructured":"Glover, T. W., Berger, C., Coyle, J. & Echo, B. DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum. Genet. 67, 136\u2013142 https:\/\/doi.org\/10.1007\/BF00272988 (1984).","journal-title":"Hum. Genet."},{"key":"979_CR132","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1440-1827.2005.01855.x","volume":"55","author":"G Guler","year":"2005","unstructured":"Guler, G. et al. Concordant loss of fragile gene expression early in breast cancer development. Pathol. Int. 55, 471\u2013478 https:\/\/doi.org\/10.1111\/j.1440-1827.2005.01855.x (2005).","journal-title":"Pathol. Int."},{"key":"979_CR133","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10549-004-1474-x","volume":"89","author":"MI Nunez","year":"2005","unstructured":"Nunez, M. I. et al. Frequent loss of WWOX expression in breast cancer: correlation with estrogen receptor status. Breast Cancer Res. Treat. 89, 99\u2013105 https:\/\/doi.org\/10.1007\/s10549-004-1474-x (2005).","journal-title":"Breast Cancer Res. Treat."},{"key":"979_CR134","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajhg.2009.01.024","volume":"84","author":"MF Arlt","year":"2009","unstructured":"Arlt, M. F. et al. Replication stress induces genome-wide copy number changes in human cells that resemble polymorphic and pathogenic variants. Am. J. Hum. Genet. 84, 339\u2013350 https:\/\/doi.org\/10.1016\/j.ajhg.2009.01.024 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"979_CR135","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","volume":"138","author":"CR Boland","year":"2010","unstructured":"Boland, C. R. & Goel, A. Microsatellite instability in colorectal cancer. Gastroenterology 138, 2073\u20132087.e3 https:\/\/doi.org\/10.1053\/j.gastro.2009.12.064 (2010).","journal-title":"Gastroenterology"},{"key":"979_CR136","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1038\/ng.3934","volume":"49","author":"P Polak","year":"2017","unstructured":"Polak, P. et al. A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer. Nat. Genet. 49, 1476\u20131486 https:\/\/doi.org\/10.1038\/ng.3934 (2017).","journal-title":"Nat. Genet."},{"key":"979_CR137","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","volume":"607","author":"M Petljak","year":"2022","unstructured":"Petljak, M. et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature 607, 799\u2013807 https:\/\/doi.org\/10.1038\/s41586-022-04972-y (2022).","journal-title":"Nature"},{"key":"979_CR138","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcad039","volume":"5","author":"VE Brown","year":"2023","unstructured":"Brown, V. E. et al. CDK2 regulates collapsed replication fork repair in CCNE1-amplified ovarian cancer cells via homologous recombination. NAR Cancer 5, zcad039 https:\/\/doi.org\/10.1093\/narcan\/zcad039 (2023).","journal-title":"NAR Cancer"},{"key":"979_CR139","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nature05327","volume":"444","author":"R Di Micco","year":"2006","unstructured":"Di Micco, R. et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 444, 638\u2013642 https:\/\/doi.org\/10.1038\/nature05327 (2006).","journal-title":"Nature"},{"key":"979_CR140","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nature05953","volume":"448","author":"D Dominguez-Sola","year":"2007","unstructured":"Dominguez-Sola, D. et al. Non-transcriptional control of DNA replication by c-Myc. Nature 448, 445\u2013451 https:\/\/doi.org\/10.1038\/nature05953 (2007).","journal-title":"Nature"},{"key":"979_CR141","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/nrc3916","volume":"15","author":"H Gaillard","year":"2015","unstructured":"Gaillard, H., Garcia-Muse, T. & Aguilera, A. Replication stress and cancer. Nat. Rev. Cancer 15, 276\u2013289 https:\/\/doi.org\/10.1038\/nrc3916 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"979_CR142","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/nature18325","volume":"535","author":"A Ray Chaudhuri","year":"2016","unstructured":"Ray Chaudhuri, A. et al. Replication fork stability confers chemoresistance in BRCA-deficient cells. Nature 535, 382\u2013387 https:\/\/doi.org\/10.1038\/nature18325 (2016).","journal-title":"Nature"},{"key":"979_CR143","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal, S. et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature 534, 47\u201354 https:\/\/doi.org\/10.1038\/nature17676 (2016).","journal-title":"Nature"},{"key":"979_CR144","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.ajpath.2012.09.011","volume":"182","author":"S Mannava","year":"2013","unstructured":"Mannava, S. et al. Depletion of deoxyribonucleotide pools is an endogenous source of DNA damage in cells undergoing oncogene-induced senescence. Am. J. Pathol. 182, 142\u2013151 https:\/\/doi.org\/10.1016\/j.ajpath.2012.09.011 (2013).","journal-title":"Am. J. Pathol."},{"key":"979_CR145","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1038\/nature06633","volume":"451","author":"W Sakai","year":"2008","unstructured":"Sakai, W. et al. Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers. Nature 451, 1116\u20131120 https:\/\/doi.org\/10.1038\/nature06633 (2008).","journal-title":"Nature"},{"key":"979_CR146","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.annonc.2020.02.008","volume":"31","author":"AG Waks","year":"2020","unstructured":"Waks, A. G. et al. Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1\/2-mutant metastatic breast cancer. Ann. Oncol. 31, 590\u2013598 https:\/\/doi.org\/10.1016\/j.annonc.2020.02.008 (2020).","journal-title":"Ann. Oncol."},{"key":"979_CR147","doi-asserted-by":"publisher","first-page":"20786","DOI":"10.1073\/pnas.1011409107","volume":"107","author":"J Doles","year":"2010","unstructured":"Doles, J. et al. Suppression of Rev3, the catalytic subunit of Pol\u03b6, sensitizes drug-resistant lung tumors to chemotherapy. Proc. Natl Acad. Sci. USA 107, 20786\u201320791 https:\/\/doi.org\/10.1073\/pnas.1011409107 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR148","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat. Genet. 45, 970\u2013976 https:\/\/doi.org\/10.1038\/ng.2702 (2013).","journal-title":"Nat. Genet."},{"key":"979_CR149","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature11881","volume":"494","author":"MB Burns","year":"2013","unstructured":"Burns, M. B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494, 366\u2013370 https:\/\/doi.org\/10.1038\/nature11881 (2013).","journal-title":"Nature"},{"key":"979_CR150","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1038\/ng.2701","volume":"45","author":"MB Burns","year":"2013","unstructured":"Burns, M. B., Temiz, N. A. & Harris, R. S. Evidence for APOBEC3B mutagenesis in multiple human cancers. Nat. Genet. 45, 977\u2013983 https:\/\/doi.org\/10.1038\/ng.2701 (2013).","journal-title":"Nat. Genet."},{"key":"979_CR151","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102700","volume":"83","author":"AM Green","year":"2019","unstructured":"Green, A. M. & Weitzman, M. D. The spectrum of APOBEC3 activity: from anti-viral agents to anti-cancer opportunities. DNA Repair 83, 102700 https:\/\/doi.org\/10.1016\/j.dnarep.2019.102700 (2019).","journal-title":"DNA Repair"},{"key":"979_CR152","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 https:\/\/doi.org\/10.1056\/NEJMoa1616288 (2017).","journal-title":"N. Engl. J. Med."},{"key":"979_CR153","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41586-023-06303-1","volume":"620","author":"H Isozaki","year":"2023","unstructured":"Isozaki, H. et al. Therapy-induced APOBEC3A drives evolution of persistent cancer cells. Nature 620, 393\u2013401 https:\/\/doi.org\/10.1038\/s41586-023-06303-1 (2023).","journal-title":"Nature"},{"key":"979_CR154","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41588-023-01592-8","volume":"56","author":"DR Caswell","year":"2024","unstructured":"Caswell, D. R. et al. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance. Nat. Genet. 56, 60\u201373 https:\/\/doi.org\/10.1038\/s41588-023-01592-8 (2024).","journal-title":"Nat. Genet."},{"key":"979_CR155","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/s41588-025-02187-1","volume":"57","author":"A Gupta","year":"2025","unstructured":"Gupta, A. et al. APOBEC3 mutagenesis drives therapy resistance in breast cancer. Nat. Genet. 57, 1452\u20131462 https:\/\/doi.org\/10.1038\/s41588-025-02187-1 (2025).","journal-title":"Nat. Genet."},{"key":"979_CR156","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41568-021-00386-6","volume":"21","author":"RM Chabanon","year":"2021","unstructured":"Chabanon, R. M. et al. Targeting the DNA damage response in immuno-oncology: developments and opportunities. Nat. Rev. Cancer 21, 701\u2013717 https:\/\/doi.org\/10.1038\/s41568-021-00386-6 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"979_CR157","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat8657","volume":"363","author":"A Ablasser","year":"2019","unstructured":"Ablasser, A. & Chen, Z. J. cGAS in action: expanding roles in immunity and inflammation. Science 363, eaat8657 https:\/\/doi.org\/10.1126\/science.aat8657 (2019).","journal-title":"Science"},{"key":"979_CR158","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-019-0556-1","volume":"21","author":"A Ablasser","year":"2020","unstructured":"Ablasser, A. & Hur, S. Regulation of cGAS- and RLR-mediated immunity to nucleic acids. Nat. Immunol. 21, 17\u201329 https:\/\/doi.org\/10.1038\/s41590-019-0556-1 (2020).","journal-title":"Nat. Immunol."},{"key":"979_CR159","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/nature23449","volume":"548","author":"KJ Mackenzie","year":"2017","unstructured":"Mackenzie, K. J. et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature 548, 461\u2013465 https:\/\/doi.org\/10.1038\/nature23449 (2017).","journal-title":"Nature"},{"key":"979_CR160","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/nature23470","volume":"548","author":"SM Harding","year":"2017","unstructured":"Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466\u2013470 https:\/\/doi.org\/10.1038\/nature23470 (2017).","journal-title":"Nature"},{"key":"979_CR161","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature25432","volume":"553","author":"SF Bakhoum","year":"2018","unstructured":"Bakhoum, S. F. et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature 553, 467\u2013472 https:\/\/doi.org\/10.1038\/nature25432 (2018).","journal-title":"Nature"},{"key":"979_CR162","doi-asserted-by":"publisher","unstructured":"Wu, I.-H. et al. RIG-I-like receptors sense replication stress through ribosomal DNA integrity to drive inflammation. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.05.27.728122 (2026).","DOI":"10.64898\/2026.05.27.728122"},{"key":"979_CR163","doi-asserted-by":"publisher","unstructured":"Chen, J. et al. rDNA breaks activate dsRNA pattern recognition through sense\u2013antisense transcription. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2026.05.26.728043 (2026).","DOI":"10.64898\/2026.05.26.728043"},{"key":"979_CR164","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.immuni.2014.10.017","volume":"41","author":"SR Woo","year":"2014","unstructured":"Woo, S. R. et al. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors. Immunity 41, 830\u2013842 https:\/\/doi.org\/10.1016\/j.immuni.2014.10.017 (2014).","journal-title":"Immunity"},{"key":"979_CR165","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","volume":"41","author":"L Deng","year":"2014","unstructured":"Deng, L. et al. STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors. Immunity 41, 843\u2013852 https:\/\/doi.org\/10.1016\/j.immuni.2014.10.019 (2014).","journal-title":"Immunity"},{"key":"979_CR166","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1158\/1078-0432.CCR-18-1821","volume":"25","author":"MT Dillon","year":"2019","unstructured":"Dillon, M. T. et al. ATR inhibition potentiates the radiation-induced inflammatory tumor microenvironment. Clin. Cancer Res. 25, 3392\u20133403 https:\/\/doi.org\/10.1158\/1078-0432.CCR-18-1821 (2019).","journal-title":"Clin. Cancer Res."},{"key":"979_CR167","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1158\/1078-0432.CCR-17-0520","volume":"23","author":"JJJ Geenen","year":"2017","unstructured":"Geenen, J. J. J. & Schellens, J. H. M. Molecular pathways: targeting the protein kinase WEE1 in cancer. Clin. Cancer Res. 23, 4540\u20134544 https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-0520 (2017).","journal-title":"Clin. Cancer Res."},{"key":"979_CR168","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","volume":"16","author":"PG Pilie","year":"2019","unstructured":"Pilie, P. G., Tang, C., Mills, G. B. & Yap, T. A. State-of-the-art strategies for targeting the DNA damage response in cancer. Nat. Rev. Clin. Oncol. 16, 81\u2013104 https:\/\/doi.org\/10.1038\/s41571-018-0114-z (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"979_CR169","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1158\/1078-0432.CCR-21-1032","volume":"27","author":"TA Yap","year":"2021","unstructured":"Yap, T. A. et al. Ceralasertib (AZD6738), an oral ATR kinase inhibitor, in combination with carboplatin in patients with advanced solid tumors: a phase I study. Clin. Cancer Res. 27, 5213\u20135224 https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1032 (2021).","journal-title":"Clin. Cancer Res."},{"key":"979_CR170","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ccell.2021.02.014","volume":"39","author":"A Thomas","year":"2021","unstructured":"Thomas, A. et al. Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress. Cancer Cell 39, 566\u2013579.e7 https:\/\/doi.org\/10.1016\/j.ccell.2021.02.014 (2021).","journal-title":"Cancer Cell"},{"key":"979_CR171","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.1005031107","volume":"107","author":"E Petermann","year":"2010","unstructured":"Petermann, E., Woodcock, M. & Helleday, T. Chk1 promotes replication fork progression by controlling replication initiation. Proc. Natl Acad. Sci. USA 107, 16090\u201316095 https:\/\/doi.org\/10.1073\/pnas.1005031107 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR172","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1158\/2159-8290.CD-11-0320","volume":"2","author":"M Aarts","year":"2012","unstructured":"Aarts, M. et al. Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1. Cancer Discov. 2, 524\u2013539 https:\/\/doi.org\/10.1158\/2159-8290.CD-11-0320 (2012).","journal-title":"Cancer Discov."},{"key":"979_CR173","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41586-022-04638-9","volume":"604","author":"D Gallo","year":"2022","unstructured":"Gallo, D. et al. CCNE1 amplification is synthetic lethal with PKMYT1 kinase inhibition. Nature 604, 749\u2013756 https:\/\/doi.org\/10.1038\/s41586-022-04638-9 (2022). This study discovers that inhibiting the kinase PKMYT1 is selectively lethal to CCNE1 amplified cancer cells by triggering premature activation of CDK1, driving these cells into unscheduled, lethal mitosis.","journal-title":"Nature"},{"key":"979_CR174","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","volume":"66","author":"AN Blackford","year":"2017","unstructured":"Blackford, A. N. & Jackson, S. P. ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response. Mol. Cell 66, 801\u2013817 https:\/\/doi.org\/10.1016\/j.molcel.2017.05.015 (2017).","journal-title":"Mol. Cell"},{"key":"979_CR175","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ccell.2019.05.001","volume":"35","author":"Y Fang","year":"2019","unstructured":"Fang, Y. et al. Sequential therapy with PARP and WEE1 inhibitors minimizes toxicity while maintaining efficacy. Cancer Cell 35, 851\u2013867.e7 https:\/\/doi.org\/10.1016\/j.ccell.2019.05.001 (2019).","journal-title":"Cancer Cell"},{"key":"979_CR176","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-64509-5","volume":"16","author":"A Thomas","year":"2025","unstructured":"Thomas, A. et al. Tumor-targeted top1 inhibitor delivery with optimized PARP inhibition in advanced solid tumors: a phase I trial of gapped scheduling. Nat. Commun. 16, 9457 https:\/\/doi.org\/10.1038\/s41467-025-64509-5 (2025).","journal-title":"Nat. Commun."},{"key":"979_CR177","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","volume":"355","author":"CJ Lord","year":"2017","unstructured":"Lord, C. J. & Ashworth, A. PARP inhibitors: synthetic lethality in the clinic. Science 355, 1152\u20131158 https:\/\/doi.org\/10.1126\/science.aam7344 (2017).","journal-title":"Science"},{"key":"979_CR178","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1093\/emboj\/cdg206","volume":"22","author":"J Menissier de Murcia","year":"2003","unstructured":"Menissier de Murcia, J. et al. Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse. EMBO J. 22, 2255\u20132263 https:\/\/doi.org\/10.1093\/emboj\/cdg206 (2003).","journal-title":"EMBO J."},{"key":"979_CR179","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1158\/0008-5472.CAN-12-2753","volume":"72","author":"J Murai","year":"2012","unstructured":"Murai, J. et al. Trapping of PARP1 and PARP2 by clinical PARP inhibitors. Cancer Res. 72, 5588\u20135599 https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-2753 (2012). This study reveals that PARP inhibitors act primarily by trapping PARP1 and PARP2 proteins onto damaged DNA, forming cytotoxic DNA\u2013protein complexes that block replication forks and drive cancer cell death more effectively than catalytic inhibition alone.","journal-title":"Cancer Res."},{"key":"979_CR180","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1158\/1535-7163.MCT-13-0803","volume":"13","author":"J Murai","year":"2014","unstructured":"Murai, J. et al. Stereospecific PARP trapping by BMN 673 and comparison with olaparib and rucaparib. Mol. Cancer Ther. 13, 433\u2013443 https:\/\/doi.org\/10.1158\/1535-7163.MCT-13-0803 (2014).","journal-title":"Mol. Cancer Ther."},{"key":"979_CR181","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2301972120","volume":"120","author":"Z Shao","year":"2023","unstructured":"Shao, Z. et al. Inactive PARP1 causes embryonic lethality and genome instability in a dominant-negative manner. Proc. Natl Acad. Sci. USA 120, e2301972120 https:\/\/doi.org\/10.1073\/pnas.2301972120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"979_CR182","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1016\/j.molcel.2024.09.020","volume":"84","author":"X Lin","year":"2024","unstructured":"Lin, X. et al. Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts. Mol. Cell 84, 3916\u20133931.e7 https:\/\/doi.org\/10.1016\/j.molcel.2024.09.020 (2024).","journal-title":"Mol. Cell"},{"key":"979_CR183","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1158\/1078-0432.CCR-22-0301","volume":"28","author":"G Illuzzi","year":"2022","unstructured":"Illuzzi, G. et al. Preclinical characterization of AZD5305, a next-generation, highly selective PARP1 inhibitor and trapper. Clin. Cancer Res. 28, 4724\u20134736 https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-0301 (2022).","journal-title":"Clin. Cancer Res."},{"key":"979_CR184","doi-asserted-by":"publisher","unstructured":"AZD5305 more tolerable than earlier PARP agents. Cancer Discov. 12, 1602 https:\/\/doi.org\/10.1158\/2159-8290.CD-NB2022-0039 (2022).","DOI":"10.1158\/2159-8290.CD-NB2022-0039"},{"key":"979_CR185","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.tcb.2019.07.008","volume":"29","author":"SM Noordermeer","year":"2019","unstructured":"Noordermeer, S. M. & van Attikum, H. PARP inhibitor resistance: a tug-of-war in BRCA-mutated cells. Trends Cell Biol. 29, 820\u2013834 https:\/\/doi.org\/10.1016\/j.tcb.2019.07.008 (2019).","journal-title":"Trends Cell Biol."},{"key":"979_CR186","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/s41586-019-1103-9","volume":"568","author":"FM Behan","year":"2019","unstructured":"Behan, F. M. et al. Prioritization of cancer therapeutic targets using CRISPR\u2013Cas9 screens. Nature 568, 511\u2013516 https:\/\/doi.org\/10.1038\/s41586-019-1103-9 (2019).","journal-title":"Nature"},{"key":"979_CR187","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/s41586-019-1102-x","volume":"568","author":"EM Chan","year":"2019","unstructured":"Chan, E. M. et al. WRN helicase is a synthetic lethal target in microsatellite unstable cancers. Nature 568, 551\u2013556 https:\/\/doi.org\/10.1038\/s41586-019-1102-x (2019).","journal-title":"Nature"},{"key":"979_CR188","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43333","volume":"8","author":"S Lieb","year":"2019","unstructured":"Lieb, S. et al. Werner syndrome helicase is a selective vulnerability of microsatellite instability-high tumor cells. eLife 8, e43333 https:\/\/doi.org\/10.7554\/eLife.43333 (2019).","journal-title":"eLife"},{"key":"979_CR189","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.isci.2019.02.006","volume":"13","author":"L Kategaya","year":"2019","unstructured":"Kategaya, L., Perumal, S. K., Hager, J. H. & Belmont, L. D. Werner syndrome helicase is required for the survival of cancer cells with microsatellite instability. iScience 13, 488\u2013497 https:\/\/doi.org\/10.1016\/j.isci.2019.02.006 (2019). Together with Behan et al. (2019), Chan et al. (2019) and Lieb et al. (2019), this study establishes WRN as a critical, selective synthetic lethal dependency and major therapeutic target specifically for MSI cancers.","journal-title":"iScience"},{"key":"979_CR190","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-26-1023","author":"T Ma","year":"2026","unstructured":"Ma, T., Wu, J., Li, S. & Chen, J. CRISPR screening identifies SMARCAL1 and MRN as modulators of WRN dependency in MSI-H colorectal cancer. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-26-1023 (2026).","journal-title":"Cancer Res."},{"key":"979_CR191","doi-asserted-by":"publisher","unstructured":"Picco, G. et al. On-target mutations confer resistance to WRN helicase inhibitors in microsatellite unstable cancer cells. Preprint at bioRxiv https:\/\/doi.org\/10.64898\/2025.12.23.695783 (2025).","DOI":"10.64898\/2025.12.23.695783"},{"key":"979_CR192","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1158\/1078-0432.CCR-23-1763","volume":"30","author":"PG Pilie","year":"2024","unstructured":"Pilie, P. G. et al. Ataxia-telangiectasia mutated loss-of-function displays variant and tissue-specific differences across tumor types. Clin. Cancer Res. 30, 2121\u20132139 https:\/\/doi.org\/10.1158\/1078-0432.CCR-23-1763 (2024).","journal-title":"Clin. Cancer Res."},{"key":"979_CR193","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1158\/2159-8290.CD-24-1500","volume":"15","author":"TA Yap","year":"2025","unstructured":"Yap, T. A. et al. Phase Ib basket expansion trial and alternative-schedule dose-escalation study of ATR inhibitor elimusertib in advanced solid tumors with DNA damage response defects. Cancer Discov. 15, 2019\u20132035 https:\/\/doi.org\/10.1158\/2159-8290.CD-24-1500 (2025).","journal-title":"Cancer Discov."},{"key":"979_CR194","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-20-0868","volume":"11","author":"TA Yap","year":"2021","unstructured":"Yap, T. A. et al. First-in-human trial of the oral ataxia telangiectasia and RAD3-related (ATR) inhibitor BAY 1895344 in patients with advanced solid tumors. Cancer Discov. 11, 80\u201391 https:\/\/doi.org\/10.1158\/2159-8290.CD-20-0868 (2021).","journal-title":"Cancer Discov."},{"key":"979_CR195","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1038\/s41388-018-0606-4","volume":"38","author":"C Wang","year":"2019","unstructured":"Wang, C. et al. Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition. Oncogene 38, 2451\u20132463 https:\/\/doi.org\/10.1038\/s41388-018-0606-4 (2019).","journal-title":"Oncogene"},{"key":"979_CR196","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1009176","volume":"16","author":"EM Schleicher","year":"2020","unstructured":"Schleicher, E. M. et al. Dual genome-wide CRISPR knockout and CRISPR activation screens identify mechanisms that regulate the resistance to multiple ATR inhibitors. PLoS Genet. 16, e1009176 https:\/\/doi.org\/10.1371\/journal.pgen.1009176 (2020).","journal-title":"PLoS Genet."},{"key":"979_CR197","doi-asserted-by":"publisher","first-page":"8214","DOI":"10.1093\/nar\/gkab643","volume":"49","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Genetic vulnerabilities upon inhibition of DNA damage response. Nucleic Acids Res. 49, 8214\u20138231 https:\/\/doi.org\/10.1093\/nar\/gkab643 (2021).","journal-title":"Nucleic Acids Res."},{"key":"979_CR198","doi-asserted-by":"publisher","first-page":"8665","DOI":"10.1093\/nar\/gkab628","volume":"49","author":"RL Lloyd","year":"2021","unstructured":"Lloyd, R. L. et al. Loss of Cyclin C or CDK8 provides ATR inhibitor resistance by suppressing transcription-associated replication stress. Nucleic Acids Res. 49, 8665\u20138683 https:\/\/doi.org\/10.1093\/nar\/gkab628 (2021).","journal-title":"Nucleic Acids Res."},{"key":"979_CR199","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S1470-2045(20)30324-7","volume":"21","author":"SM Domchek","year":"2020","unstructured":"Domchek, S. M. et al. Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1\/2, basket study. Lancet Oncol. 21, 1155\u20131164 https:\/\/doi.org\/10.1016\/S1470-2045(20)30324-7 (2020).","journal-title":"Lancet Oncol."},{"key":"979_CR200","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","volume":"18","author":"MJ Overman","year":"2017","unstructured":"Overman, M. J. et al. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Lancet Oncol. 18, 1182\u20131191 https:\/\/doi.org\/10.1016\/S1470-2045(17)30422-9 (2017).","journal-title":"Lancet Oncol."},{"key":"979_CR201","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1200\/JCO.19.02107","volume":"38","author":"DT Le","year":"2020","unstructured":"Le, D. T. et al. Phase II open-label study of pembrolizumab in treatment-refractory, microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: KEYNOTE-164. J. Clin. Oncol. 38, 11\u201319 https:\/\/doi.org\/10.1200\/JCO.19.02107 (2020).","journal-title":"J. Clin. Oncol."},{"key":"979_CR202","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.19.02105","volume":"38","author":"A Marabelle","year":"2020","unstructured":"Marabelle, A. et al. Efficacy of pembrolizumab in patients with noncolorectal high microsatellite instability\/mismatch repair-deficient cancer: results from the phase II KEYNOTE-158 study. J. Clin. Oncol. 38, 1\u201310 https:\/\/doi.org\/10.1200\/JCO.19.02105 (2020).","journal-title":"J. Clin. Oncol."},{"key":"979_CR203","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41591-020-0805-8","volume":"26","author":"M Chalabi","year":"2020","unstructured":"Chalabi, M. et al. Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers. Nat. Med. 26, 566\u2013576 https:\/\/doi.org\/10.1038\/s41591-020-0805-8 (2020).","journal-title":"Nat. Med."},{"key":"979_CR204","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andre","year":"2020","unstructured":"Andre, T. et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl. J. Med. 383, 2207\u20132218 https:\/\/doi.org\/10.1056\/NEJMoa2017699 (2020).","journal-title":"N. Engl. J. Med."},{"key":"979_CR205","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1158\/2159-8290.CD-21-0219","volume":"11","author":"M Kwon","year":"2021","unstructured":"Kwon, M. et al. Determinants of response and intrinsic resistance to PD-1 blockade in microsatellite instability-high gastric cancer. Cancer Discov. 11, 2168\u20132185 https:\/\/doi.org\/10.1158\/2159-8290.CD-21-0219 (2021).","journal-title":"Cancer Discov."},{"key":"979_CR206","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1200\/JCO.21.01015","volume":"40","author":"HJ Lenz","year":"2022","unstructured":"Lenz, H. J. et al. First-line nivolumab plus low-dose ipilimumab for microsatellite instability-high\/mismatch repair-deficient metastatic colorectal cancer: the phase II CheckMate 142 study. J. Clin. Oncol. 40, 161\u2013170 https:\/\/doi.org\/10.1200\/JCO.21.01015 (2022).","journal-title":"J. Clin. Oncol."},{"key":"979_CR207","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman, I., Chen, D. S., Powles, T. & Turley, S. J. The cancer-immunity cycle: indication, genotype, and immunotype. Immunity 56, 2188\u20132205 https:\/\/doi.org\/10.1016\/j.immuni.2023.09.011 (2023).","journal-title":"Immunity"},{"key":"979_CR208","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03682289 (2026)."},{"key":"979_CR209","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02223923 (2025)."},{"key":"979_CR210","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04704661 (2026)."},{"key":"979_CR211","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04497116 (2025)."},{"key":"979_CR212","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04972110 (2025)."},{"key":"979_CR213","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04267939 (2023)."},{"key":"979_CR214","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04535401 (2026)."},{"key":"979_CR215","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04616534 (2026)."},{"key":"979_CR216","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02487095 (2025)."},{"key":"979_CR217","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02589522 (2026)."},{"key":"979_CR218","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02567409 (2025)."},{"key":"979_CR219","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02203513 (2022)."},{"key":"979_CR220","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02873975 (2022)."},{"key":"979_CR221","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03057145 (2021)."},{"key":"979_CR222","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02797964 (2023)."},{"key":"979_CR223","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02797977 (2023)."},{"key":"979_CR224","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02659241 (2026)."},{"key":"979_CR225","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04460937 (2026)."},{"key":"979_CR226","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02617277 (2026)."},{"key":"979_CR227","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT03253679 (2023)."},{"key":"979_CR228","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04855656 (2026)."},{"key":"979_CR229","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05605509 (2026)."},{"key":"979_CR230","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT04644068 (2026)."},{"key":"979_CR231","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06120491 (2026)."},{"key":"979_CR232","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT05838768 (2026)."},{"key":"979_CR233","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT06004245 (2026)."},{"key":"979_CR234","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02588105 (2022)."},{"key":"979_CR235","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/study\/NCT02516813 (2024)."},{"key":"979_CR236","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/s41594-023-00928-6","volume":"30","author":"H Stoy","year":"2023","unstructured":"Stoy, H. et al. Direct visualization of transcription\u2013replication conflicts reveals post-replicative DNA:RNA hybrids. Nat. Struct. Mol. Biol. 30, 348\u2013359 https:\/\/doi.org\/10.1038\/s41594-023-00928-6 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"979_CR237","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111998","volume":"42","author":"V Mengoli","year":"2023","unstructured":"Mengoli, V. et al. WRN helicase and mismatch repair complexes independently and synergistically disrupt cruciform DNA structures. EMBO J. 42 e111998 https:\/\/doi.org\/10.15252\/embj.2022111998 (2023).","journal-title":"EMBO J."},{"key":"979_CR238","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.molcel.2006.09.010","volume":"24","author":"IF Davidson","year":"2006","unstructured":"Davidson, I. F., Li, A. & Blow, J. J. Deregulated replication licensing causes DNA fragmentation consistent with head-to-tail fork collision. Mol. Cell 24, 433\u2013443 https:\/\/doi.org\/10.1016\/j.molcel.2006.09.010 (2006).","journal-title":"Mol. Cell"},{"key":"979_CR239","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.molcel.2013.09.021","volume":"52","author":"J Huang","year":"2013","unstructured":"Huang, J. et al. The DNA translocase FANCM\/MHF promotes replication traverse of DNA interstrand crosslinks. Mol. Cell 52, 434\u2013446 https:\/\/doi.org\/10.1016\/j.molcel.2013.09.021 (2013).","journal-title":"Mol. Cell"},{"key":"979_CR240","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/78169","volume":"25","author":"L Haracska","year":"2000","unstructured":"Haracska, L., Yu, S. L., Johnson, R. E., Prakash, L. & Prakash, S. Efficient and accurate replication in the presence of 7,8-dihydro-8-oxoguanine by DNA polymerase eta. Nat. Genet. 25, 458\u2013461 https:\/\/doi.org\/10.1038\/78169 (2000).","journal-title":"Nat. Genet."},{"key":"979_CR241","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1101\/gad.950302","volume":"16","author":"L Zou","year":"2002","unstructured":"Zou, L., Cortez, D. & Elledge, S. J. Regulation of ATR substrate selection by Rad17-dependent loading of Rad9 complexes onto chromatin. Genes Dev. 16, 198\u2013208 https:\/\/doi.org\/10.1101\/gad.950302 (2002).","journal-title":"Genes Dev."},{"key":"979_CR242","first-page":"1","volume":"97","author":"L Zou","year":"2001","unstructured":"Zou, L. & Elledge, S. J. Sensing and signaling DNA damage: roles of Rad17 and Rad9 complexes in the cellular response to DNA damage. Harvey Lect. 97, 1\u201315 (2001).","journal-title":"Harvey Lect."},{"key":"979_CR243","doi-asserted-by":"publisher","first-page":"28036","DOI":"10.1074\/jbc.M704635200","volume":"282","author":"J Lee","year":"2007","unstructured":"Lee, J., Kumagai, A. & Dunphy, W. G. The Rad9-Hus1-Rad1 checkpoint clamp regulates interaction of TopBP1 with ATR. J. Biol. Chem. 282, 28036\u201328044 https:\/\/doi.org\/10.1074\/jbc.M704635200 (2007).","journal-title":"J. Biol. Chem."},{"key":"979_CR244","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1101\/gad.1547007","volume":"21","author":"S Delacroix","year":"2007","unstructured":"Delacroix, S., Wagner, J. M., Kobayashi, M., Yamamoto, K. & Karnitz, L. M. The Rad9-Hus1-Rad1 (9-1-1) clamp activates checkpoint signaling via TopBP1. Genes Dev. 21, 1472\u20131477 https:\/\/doi.org\/10.1101\/gad.1547007 (2007).","journal-title":"Genes Dev."},{"key":"979_CR245","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1126\/science.288.5470.1425","volume":"288","author":"N Mailand","year":"2000","unstructured":"Mailand, N. et al. Rapid destruction of human Cdc25A in response to DNA damage. Science 288, 1425\u20131429 https:\/\/doi.org\/10.1126\/science.288.5470.1425 (2000).","journal-title":"Science"},{"key":"979_CR246","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.bcp.2015.11.022","volume":"100","author":"M Beyaert","year":"2016","unstructured":"Beyaert, M., Starczewska, E., Van Den Neste, E. & Bontemps, F. A crucial role for ATR in the regulation of deoxycytidine kinase activity. Biochem. Pharmacol. 100, 40\u201350 https:\/\/doi.org\/10.1016\/j.bcp.2015.11.022 (2016).","journal-title":"Biochem. Pharmacol."},{"key":"979_CR247","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/bs.mie.2017.03.019","volume":"591","author":"A Quinet","year":"2017","unstructured":"Quinet, A., Carvajal-Maldonado, D., Lemacon, D. & Vindigni, A. DNA fiber analysis: mind the gap! Methods Enzymol. 591, 55\u201382 https:\/\/doi.org\/10.1016\/bs.mie.2017.03.019 (2017).","journal-title":"Methods Enzymol."},{"key":"979_CR248","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkag212","volume":"54","author":"N Kara","year":"2026","unstructured":"Kara, N. et al. Multiplexed TrAEL-seq captures DNA replication dynamics in mammalian cells. Nucleic Acids Res. 54, gkag212 https:\/\/doi.org\/10.1093\/nar\/gkag212 (2026).","journal-title":"Nucleic Acids Res."},{"key":"979_CR249","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000886","volume":"19","author":"N Kara","year":"2021","unstructured":"Kara, N., Krueger, F., Rugg-Gunn, P. & Houseley, J. Genome-wide analysis of DNA replication and DNA double-strand breaks using TrAEL-seq. PLoS Biol. 19, e3000886 https:\/\/doi.org\/10.1371\/journal.pbio.3000886 (2021).","journal-title":"PLoS Biol."},{"key":"979_CR250","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68750-4","volume":"17","author":"V Rojat","year":"2026","unstructured":"Rojat, V. et al. Automated mapping of DNA replication fork progression in human cells with ForkML. Nat. Commun. 17, 1975 https:\/\/doi.org\/10.1038\/s41467-026-68750-4 (2026).","journal-title":"Nat. Commun."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00979-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00979-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:12:38Z","timestamp":1790093558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00979-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":250,"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1038\/s41568-026-00979-z","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"18 August 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}